JP2001518077A5 - - Google Patents

Download PDF

Info

Publication number
JP2001518077A5
JP2001518077A5 JP1998536676A JP53667698A JP2001518077A5 JP 2001518077 A5 JP2001518077 A5 JP 2001518077A5 JP 1998536676 A JP1998536676 A JP 1998536676A JP 53667698 A JP53667698 A JP 53667698A JP 2001518077 A5 JP2001518077 A5 JP 2001518077A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998536676A
Other languages
English (en)
Japanese (ja)
Other versions
JP4215827B2 (ja
JP2001518077A (ja
Filing date
Publication date
Priority claimed from US08/803,364 external-priority patent/US5864014A/en
Priority claimed from US09/024,198 external-priority patent/US5912323A/en
Application filed filed Critical
Publication of JP2001518077A publication Critical patent/JP2001518077A/ja
Publication of JP2001518077A5 publication Critical patent/JP2001518077A5/ja
Application granted granted Critical
Publication of JP4215827B2 publication Critical patent/JP4215827B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53667698A 1997-02-20 1998-02-18 閉鎖帯毒素レセプター Expired - Fee Related JP4215827B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/803,364 1997-02-20
US08/803,364 US5864014A (en) 1997-02-20 1997-02-20 Zonula occludens toxin receptor
US09/024,198 1998-02-17
US09/024,198 US5912323A (en) 1997-02-20 1998-02-17 Zonula occludens toxin receptors
PCT/US1998/002257 WO1998037096A1 (en) 1997-02-20 1998-02-18 Zonula occludens toxin receptors

Publications (3)

Publication Number Publication Date
JP2001518077A JP2001518077A (ja) 2001-10-09
JP2001518077A5 true JP2001518077A5 (enExample) 2005-10-06
JP4215827B2 JP4215827B2 (ja) 2009-01-28

Family

ID=26698164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53667698A Expired - Fee Related JP4215827B2 (ja) 1997-02-20 1998-02-18 閉鎖帯毒素レセプター

Country Status (9)

Country Link
US (2) US5912323A (enExample)
EP (1) EP1007553B1 (enExample)
JP (1) JP4215827B2 (enExample)
AT (1) ATE359294T1 (enExample)
AU (1) AU6270298A (enExample)
CA (1) CA2281617A1 (enExample)
DE (1) DE69837546T2 (enExample)
ES (1) ES2285762T3 (enExample)
WO (1) WO1998037096A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
EP1249244A1 (en) 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
WO2003077893A2 (fr) * 2002-03-15 2003-09-25 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
EP2218790A3 (en) 2002-09-06 2010-08-25 Promega Corporation Kits for detecting transferase enzymatic activity
JP4485470B2 (ja) 2002-12-23 2010-06-23 プロメガ コーポレイション ルシフェラーゼ酵素活性を保護するための方法及びキット
CA2531491A1 (en) * 2003-07-15 2005-02-03 University Of Maryland, Baltimore Agonist polypeptide of receptor for zot and zonulin
US20080038843A1 (en) * 2006-08-11 2008-02-14 University Of Maryland - Baltimore Method of diagnosing celiac disease
WO2006088491A2 (en) * 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
TW200637573A (en) * 2005-01-14 2006-11-01 Univ Maryland Peptide for delivery of mucosal vaccines
TW200716159A (en) * 2005-06-09 2007-05-01 Univ Maryland Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
BRPI0707616A2 (pt) 2006-02-09 2011-05-10 Alba Therapuetics Corp formulaÇÕes para um efetor de junÇço oclusiva
US20090069247A1 (en) * 2006-10-06 2009-03-12 Blake Paterson Use of tight junction antagonists to treat inflammatory bowel disease
US8034776B2 (en) * 2006-10-26 2011-10-11 Alba Therapeutics Corporation Materials and methods for the treatment of celiac disease
EP2091551B1 (en) 2006-11-03 2020-01-15 Alba Therapeutics Corporation Method of treating asthma
US8728491B2 (en) * 2007-05-07 2014-05-20 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
WO2009006246A1 (en) * 2007-06-29 2009-01-08 Alea Therapeutics Corp. Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
WO2009015382A2 (en) 2007-07-26 2009-01-29 Alba Therapeutics Corporation Novel peptides that enhance tight junction permeability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2000509637A5 (enExample)
JP2000509635A5 (enExample)
JP2000509587A5 (enExample)
JP2002507251A5 (enExample)
JP2001524206A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2001518081A5 (enExample)
JP2000508841A5 (enExample)
JP2002510343A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2001524146A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2001518077A5 (enExample)
JP2000508880A5 (enExample)